IFITM1 and Epstein-Barr virus infection: Notably, IFITM1 knockdown weakened HK1 cells’ defence against EBV (Extended Data Fig. 2d–i), while its overexpression enhanced the anti-EBV infection ability in NP69 and HEK293 cells (Extended Data Fig. 3c–h).